Under the lens: Taking a close look at the NIH and FDA declarations on animal-based research

No need for a speculum? A new era of HPV screening

FDA has cleared the first at-home self-collection kit for HPV screening, removing significant obstacles to cervical cancer detection.

April 22, 2026

Health Equity Regulatory News

Self-collection kits for HPV are among innovations adding momentum to eradication of cervical cancer
A kit for at-home unsupervised self-collection clears FDA finish line

Boca Raton resident Gabriela Sanchez recently found herself stepping into a mobile outreach vehicle operated by Sylvester Comprehensive Cancer Center.

April 17, 2026

Vol.52 No.15

By Claire Marie Porter

Cancer History Project Editorial

Calabresi’s “Cancer at a Crossroads” report was the first step toward historic doubling of the NIH budget
Fox Chase’s Winn contemplates Crossroads 2.0

At a lecture at Yale Cancer Center recently, Robert A. Winn brandished a copy of a 32-year old booklet titled “Cancer at a Crossroads: A Report to Congress for the Nation,” using it as a show-and-tell prop in arguing that America’s cancer program is once again at a crossroads and therefore in urgent need of strategic thinking (The Cancer Letter, April 10, 2026).

FDA adds stereotactic breast biopsy needles to the shortage list

FDA has added stereotactic breast biopsy needles to its Medical Device Shortages List with an estimated duration of “through Q4 2026,” which spans July 1 to Sept. 30.

FDA issues reminder to sponsors: Disclose clinical trial results

FDA issued a stern reminder to medical product companies and researchers of the requirements to submit certain clinical trial results information to ClinicalTrials.gov.

Health groups urge Bhattacharya, in his position of acting CDC director, to restore staff in the Office on Smoking and Health

A coalition of public health groups sent a formal letter to NIH Director and Acting CDC Director Jay Bhattacharya April 15 highlighting the need for the immediate restoration of full staffing and resources to the CDC’s Office on Smoking and Health.

April 17, 2026

Vol.52 No.15

By Jacquelyn Cobb

Under the lens: Taking a close look at the NIH and FDA declarations on animal-based research

YOU MAY BE INTERESTED IN

No need for a speculum? A new era of HPV screening

Self-collection kits for HPV are among innovations adding momentum to eradication of cervical cancer
A kit for at-home unsupervised self-collection clears FDA finish line

Calabresi’s “Cancer at a Crossroads” report was the first step toward historic doubling of the NIH budget
Fox Chase’s Winn contemplates Crossroads 2.0

FDA adds stereotactic breast biopsy needles to the shortage list

FDA issues reminder to sponsors: Disclose clinical trial results

Health groups urge Bhattacharya, in his position of acting CDC director, to restore staff in the Office on Smoking and Health

Renew today!

Subscriber content

Never miss an issue!

Login

Under the lens: Taking a close look at the NIH and FDA declarations on animal-based research

YOU MAY BE INTERESTED IN

No need for a speculum? A new era of HPV screening

Self-collection kits for HPV are among innovations adding momentum to eradication of cervical cancerA kit for at-home unsupervised self-collection clears FDA finish line

Calabresi’s “Cancer at a Crossroads” report was the first step toward historic doubling of the NIH budgetFox Chase’s Winn contemplates Crossroads 2.0

FDA adds stereotactic breast biopsy needles to the shortage list

FDA issues reminder to sponsors: Disclose clinical trial results

Health groups urge Bhattacharya, in his position of acting CDC director, to restore staff in the Office on Smoking and Health

Never miss an issue!

Login

Self-collection kits for HPV are among innovations adding momentum to eradication of cervical cancer
A kit for at-home unsupervised self-collection clears FDA finish line

Calabresi’s “Cancer at a Crossroads” report was the first step toward historic doubling of the NIH budget
Fox Chase’s Winn contemplates Crossroads 2.0